Psychiatry Research
Volume 120, Issue 3 , Pages 283-293 , 15 October 2003

Respiratory panic disorder subtype: acute and long-term response to nortriptyline, a noradrenergic tricyclic antidepressant

  • Antonio E. Nardi

      Affiliations

    • Laboratory of Panic and Respiration, Institute of Psychiatry–IPUB, Federal University of Rio de Janeiro, R. Visconde de Pirajá, 407/702, Rio de Janeiro-RJ-22410-003, Brazil
    • Corresponding Author InformationCorresponding author. Tel.: +55 21-2521-6147; fax: +55 21-2523-6839
    • ,
  • Isabella Nascimento

      Affiliations

    • Laboratory of Panic and Respiration, Institute of Psychiatry–IPUB, Federal University of Rio de Janeiro, R. Visconde de Pirajá, 407/702, Rio de Janeiro-RJ-22410-003, Brazil
    • ,
  • Alexandre M. Valença

      Affiliations

    • Laboratory of Panic and Respiration, Institute of Psychiatry–IPUB, Federal University of Rio de Janeiro, R. Visconde de Pirajá, 407/702, Rio de Janeiro-RJ-22410-003, Brazil
    • ,
  • Fabiana L. Lopes

      Affiliations

    • Laboratory of Panic and Respiration, Institute of Psychiatry–IPUB, Federal University of Rio de Janeiro, R. Visconde de Pirajá, 407/702, Rio de Janeiro-RJ-22410-003, Brazil
    • ,
  • Marco A. Mezzasalma

      Affiliations

    • Laboratory of Panic and Respiration, Institute of Psychiatry–IPUB, Federal University of Rio de Janeiro, R. Visconde de Pirajá, 407/702, Rio de Janeiro-RJ-22410-003, Brazil
    • ,
  • Walter A. Zin

      Affiliations

    • Laboratory of Respiration Physiology. Carlos Chagas Filho Biophysics Institute. Federal University of Rio de Janeiro, Rio de Janeiro, Brazil
    • ,
  • Marcio Versiani

      Affiliations

    • Laboratory of Panic and Respiration, Institute of Psychiatry–IPUB, Federal University of Rio de Janeiro, R. Visconde de Pirajá, 407/702, Rio de Janeiro-RJ-22410-003, Brazil

Received 9 May 2002 ,Revised 16 January 2003 ,Accepted 16 May 2003.

References 

  1. American Psychiatric Association. Diagnostic and Statistical Manual for Mental Disorders-DSM-IV. 4th ed. Washington, DC: American Psychiatric Press; 1994;
  2. Aronson TA. Treatment-emergent depression with antidepressants in panic disorder. Comprehensive Psychiatry. 1989;30:267–271
  3. Ballenger JC. Pharmacotherapy of the panic disorders. Journal of Clinical Psychiatry. 1986;47(Suppl. 6):27–32
  4. Bennett JA, Moioffer M, Stanton SP, Dwight M, Keck PE. A risk-benefit assessment of pharmacological treatments for panic disorder. Drug Safety. 1998;18:419–430
  5. Biber B, Alkin T. Panic disorder subtypes: differential responses to CO2 challenge. American Journal of Psychiatry. 1999;156:739–744
  6. Briggs AC, Stretch DD, Brandon S. Subtyping of panic disorder by symptom profile. British Journal of Psychiatry. 1993;163:201–209
  7. Charney DS, Bremner JD, Redmond DE. Noradrenergic neuronal substrates for anxiety and fear: clinical associations based on preclinical research. In:  Bloom FE,  Kupfer DJ editor. Psychopharmacology: The Fourth Generation of Progress. New York: Raven Press; 1995;p. 387–396
  8. Coplan JD, Papp LA, Pine D, Martinez J, Cooper T, Rosenblum LA, et al. Clinical improvement with fluoxetine therapy and noradrenergic function in patients with panic disorder. Archives of General Psychiatry. 1997;54:643–648
  9. Coplan JD, Tiffon L, Gorman JM. Therapeutic strategies for the patient with treatment-resistant anxiety. Journal of Clinical Psychiatry. 1993;54(Suppl.):69–74
  10. den Boer JA, Westenberg HG. Effect of a serotonin and noradrenaline uptake inhibitor in panic disorder; a double-blind comparative study with fluvoxamine and maprotiline. International Clinical Psychopharmacology. 1988;3:59–74
  11. Endicott J, Nee J, Harrison W, Blumenthal R. Quality of life enjoyment and satisfaction questionnaire: a new measure. Psychopharmacology Bulletin. 1993;29:321–326
  12. First MB, Spitzer RL, Gibbon M, Williams JBM. Structured Clinical Interview (SCID) for DSM-IV Axis I Disorders-Clinician Version (SCID-CV). Washington, DC: American Psychiatric Press; 1997;
  13. Gorman JM. The use of newer antidepressants for panic disorder. Journal of Clinical Psychiatry. 1997;58(Suppl. 14):54–58
  14. Gorman JM, Kent JM, Sullivan GM, Coplan JD. Neuroanatomical hypothesis of panic disorder, revised. American Journal of Psychiatry. 2000;151:547–553
  15. ECDEU Assessment Manual for Psychopharmacology, Revised. In:  Guy W editors. National Institute of Mental Health. Rockville, MD: Department of Health, Education, and Welfare Publication; 1976;
  16. Hamilton M. The assessment of anxiety states by rating. British Journal of Medical Psychology. 1959;32:50–55
  17. Hamilton M. A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry. 1960;23:56–62
  18. Klein DF. False suffocation alarms, spontaneous panics, and related conditions. An integrative hypothesis. Archives of General Psychiatry. 1993;50:306–317
  19. Klein DF, Klein HM. The status of panic disorder. Current Opinion in Psychiatry. 1988;1:177–183
  20. Munjack DJ, Usigli R, Zulueta A, Crocker B, Adatia N, Buckwalter JG, et al. Nortriptyline in the treatment of panic disorder and agoraphobia with panic attacks. Journal of Clinical Psychopharmacology. 1988;8:204–207
  21. Nutt D, Lawson C. Panic attacks. A neurochemical overview of models and mechanisms. British Journal of Psychiatry. 1992;160:165–178
  22. Rapaport MH, Pollack M, Wolkow R, Mardekian J, Clary C. Is placebo response the same as drug response in panic disorder?. American Journal of Psychiatry. 2000;157:1014–1016
  23. Shear MK, Brown TA, Barlow DH, Money R, Sholomskas D, Woods SW, et al. Multicenter collaborative panic disorder severity scale. American Journal of Psychiatry. 1997;154:1571–1575
  24. Sheehan DV. The Anxiety Disease. New York: Charles Scribner & Sons; 1983;
  25. Sheehan DV. Current concepts in the treatment of panic disorder. Journal of Clinical Psychiatry. 1999;60(Suppl. 18):16–21
  26. Versiani M, Cassano G, Perugi G, Benedetti A, Mastalli L, Nardi AE, et al. Reboxetine, a selective norepinephrine reuptake inhibitor, is an effective and well-tolerated treatment for panic disorder. Journal of Clinical Psychiatry. 2002;63:31–37

PII: S0165-1781(03)00132-X

doi: 10.1016/S0165-1781(03)00132-X

Psychiatry Research
Volume 120, Issue 3 , Pages 283-293 , 15 October 2003

Article Tools